I 20 sider rapport hedder det, at”Twenty-nine percent of CEOs are very optimistic or optimistic about the global economy, while 23% are pessimistic or very pessimistic. One bright spot of optimism: no ...
Bagsværd, Denmark, 20 September 2024 – Novo Nordisk today announced headline results from a phase 2a clinical trial with monlunabant, a small molecule oral cannabinoid receptor 1 (CB1) inverse agonist ...
The initiative will launch in six cities across five continents Interventions aim to increase physical activity and healthy eating among children The three-year initiative comes with an investment of ...